Well over 1,000 claims have been filed in the Lipitor diabetes litigation since it was established this past February.
New York, New York (PRWEB) November 22, 2014
Lipitor lawsuits (http://www.lipitorlawsuitcenter.com/) that have been filed on behalf of patients who allegedly developed Type 2 diabetes due to its use continue to move forward in the federal multidistrict litigation now underway in U.S. District Court, District of South Carolina, Bernstein Liebhard LLP reports. According to court documents, the litigation will convene its next Status Conference on December 18th at 10:00 a.m. The Court has directed Lead Counsel for Plaintiffs and Defendants to meet and confer, and to submit a Joint Status Report at least five business days prior to the Conference. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)
“Well over 1,000 claims have been filed in the Lipitor diabetes litigation since it was established this past February. We continue to hear from individuals who allegedly developed diabetes due to their use of this statin, and look forward to next month’s conference and continued progress in the litigation,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free and confidential case reviews to individuals who may have been harmed by Lipitor.
Lipitor Diabetes Allegations
Lipitor is a statin that is used to lower LDL or “bad” cholesterol and reduce the risks of heart attacks, strokes and certain heart surgeries in people who have heart disease, as well as those who have risk factors for heart disease. In February 2012, the U.S. Food & Drug Administration (FDA) announced that the labels of Lipitor and other statins would be updated to include new information about their potential association with Type 2 diabetes. The announcement followed the publication of a study in JAMA: Internal Medicine the previous month which suggested that post-menopausal women treated with statins faced an increased risk of developing new-onset Type 2 diabetes. *
Since then, court documents indicate that more than 1,400 Lipitor lawsuits have been filed in the District of South Carolina, all which accuse Pfizer Inc. of concealing information about the drug’s association with diabetes in order to protect sales of the medication. Plaintiffs further allege that had Pfizer provided doctors and the public with adequate warnings about the risk of diabetes, they would have chosen not to use the medication, or could have diligently monitored their blood glucose levels in order to avoid developing the disease.
Lipitor patients who allegedly developed Type 2 diabetes while using this medication may be entitled to compensation from Pfizer. To learn more about filing a Lipitor lawsuit, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.
*archinte.jamanetwork.com/article.aspx?articleid=1108676, JAMA Internal Medicine, January 2012
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com